Literature DB >> 29296789

Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?

Claire Schwab1, Karin Nebral2, Lucy Chilton1, Cristina Leschi3,4, Esmé Waanders5, Judith M Boer6, Markéta Žaliová7,8, Rosemary Sutton9, Ingegerd Ivanov Öfverholm10, Kentaro Ohki11, Yuka Yamashita12, Stefanie Groeneveld-Krentz13, Eva Froňková8, Marleen Bakkus14, Joelle Tchinda15, Thayana da Conceição Barbosa16, Grazia Fazio17, Wojciech Mlynarski18, Agata Pastorczak18, Giovanni Cazzaniga17, Maria S Pombo-de-Oliveira16, Jan Trka8, Renate Kirschner-Schwabe13,19, Toshihiko Imamura20, Gisela Barbany10, Martin Stanulla21, Andishe Attarbaschi22, Renate Panzer-Grümayer2, Roland P Kuiper5, Monique L den Boer6,23, Hélène Cavé3,4, Anthony V Moorman1, Christine J Harrison1, Sabine Strehl2.   

Abstract

Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome.

Entities:  

Year:  2017        PMID： 29296789      PMCID： PMC5728462          DOI： 10.1182/bloodadvances.2017006734

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


  23 in total

Review 1.  Pax5: a master regulator of B cell development and leukemogenesis.

Authors:  Jasna Medvedovic; Anja Ebert; Hiromi Tagoh; Meinrad Busslinger
Journal:  Adv Immunol       Date:  2011       Impact factor: 3.543

2.  PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5.

Authors:  G Fazio; V Cazzaniga; C Palmi; M Galbiati; M Giordan; G te Kronnie; A Rolink; A Biondi; G Cazzaniga
Journal:  Leukemia       Date:  2012-10-01       Impact factor: 11.528

3.  Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.

Authors:  S Krentz; J Hof; A Mendioroz; R Vaggopoulou; P Dörge; C Lottaz; J C Engelmann; T W L Groeneveld; G Körner; K Seeger; C Hagemeier; G Henze; C Eckert; A von Stackelberg; R Kirschner-Schwabe
Journal:  Leukemia       Date:  2012-06-13       Impact factor: 11.528

4.  Functional heterogeneity of PAX5 chimeras reveals insight for leukemia development.

Authors:  Klaus Fortschegger; Stefanie Anderl; Dagmar Denk; Sabine Strehl
Journal:  Mol Cancer Res       Date:  2014-01-16       Impact factor: 5.852

5.  Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia?

Authors:  Rachel L Harris; Christine J Harrison; Mary Martineau; Kerry E Taylor; Anthony V Moorman
Journal:  Cancer Genet Cytogenet       Date:  2004-01-15

6.  Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.

Authors:  Claire J Schwab; Lucy Chilton; Heather Morrison; Lisa Jones; Halima Al-Shehhi; Amy Erhorn; Lisa J Russell; Anthony V Moorman; Christine J Harrison
Journal:  Haematologica       Date:  2013-03-18       Impact factor: 9.941

7.  A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups.

Authors:  Sarina Sulong; Anthony V Moorman; Julie A E Irving; Jonathan C Strefford; Zoe J Konn; Marian C Case; Lynne Minto; Kerry E Barber; Helen Parker; Sarah L Wright; Adam R M Stewart; Simon Bailey; Nick P Bown; Andrew G Hall; Christine J Harrison
Journal:  Blood       Date:  2008-10-06       Impact factor: 22.113

Review 8.  Relapsed childhood acute lymphoblastic leukaemia.

Authors:  Deepa Bhojwani; Ching-Hon Pui
Journal:  Lancet Oncol       Date:  2013-05       Impact factor: 41.316

9.  Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.

Authors:  Arian van der Veer; Esmé Waanders; Rob Pieters; Marieke E Willemse; Simon V Van Reijmersdal; Lisa J Russell; Christine J Harrison; William E Evans; Vincent H J van der Velden; Peter M Hoogerbrugge; Frank Van Leeuwen; Gabriele Escherich; Martin A Horstmann; Leila Mohammadi Khankahdani; Dimitris Rizopoulos; Hester A De Groot-Kruseman; Edwin Sonneveld; Roland P Kuiper; Monique L Den Boer
Journal:  Blood       Date:  2013-08-23       Impact factor: 22.113

10.  Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL.

Authors:  Maria Morak; Andishe Attarbaschi; Susanna Fischer; Christine Nassimbeni; Reinhard Grausenburger; Stephan Bastelberger; Stefanie Krentz; Gunnar Cario; David Kasper; Klaus Schmitt; Lisa J Russell; Ulrike Pötschger; Martin Stanulla; Conny Eckert; Georg Mann; Oskar A Haas; Renate Panzer-Grümayer
Journal:  Blood       Date:  2012-10-22       Impact factor: 22.113
View more
  15 in total

Review 1.  How advanced are we in targeting novel subtypes of ALL?

Authors:  Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2019-10-18       Impact factor: 3.020

2.  Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL.

Authors:  Lina Hamadeh; Amir Enshaei; Claire Schwab; Cristina N Alonso; Andishe Attarbaschi; Gisela Barbany; Monique L den Boer; Judith M Boer; Marcin Braun; Luciano Dalla Pozza; Sarah Elitzur; Mariana Emerenciano; Larisa Fechina; Maria Sara Felice; Eva Fronkova; Irén Haltrich; Mats M Heyman; Keizo Horibe; Toshihiko Imamura; Marta Jeison; Gábor Kovács; Roland P Kuiper; Wojciech Mlynarski; Karin Nebral; Ingegerd Ivanov Öfverholm; Agata Pastorczak; Rob Pieters; Henriett Piko; Maria S Pombo-de-Oliveira; Patricia Rubio; Sabine Strehl; Jan Stary; Rosemary Sutton; Jan Trka; Grigory Tsaur; Nicola Venn; Ajay Vora; Mio Yano; Christine J Harrison; Anthony V Moorman
Journal:  Blood Adv       Date:  2019-01-22

3.  Gene expression of ASNS, LGMN and CTSB is elevated in a subgroup of childhood BCP-ALL with PAX5 deletion.

Authors:  Ewa Wrona; Justyna Jakubowska; Bartłomiej Pawlik; Agata Pastorczak; Joanna Madzio; Monika Lejman; Łukasz Sędek; Jerzy Kowalczyk; Tomasz Szczepański; Wojciech Młynarski
Journal:  Oncol Lett       Date:  2019-11-04       Impact factor: 2.967

Review 4.  Advances in germline predisposition to acute leukaemias and myeloid neoplasms.

Authors:  Jeffery M Klco; Charles G Mullighan
Journal:  Nat Rev Cancer       Date:  2020-12-16       Impact factor: 60.716

5.  MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia.

Authors:  Chih-Hsiang Yu; Tze-Kang Lin; Shiann-Tarng Jou; Chien-Yu Lin; Kai-Hsin Lin; Meng-Yao Lu; Shu-Huey Chen; Chao-Neng Cheng; Kang-Hsi Wu; Shih-Chung Wang; Hsiu-Hao Chang; Meng-Ju Li; Yu-Ling Ni; Yi-Ning Su; Dong-Tsamn Lin; Hsuan-Yu Chen; Christine J Harrison; Chia-Cheng Hung; Shu-Wha Lin; Yung-Li Yang
Journal:  Sci Rep       Date:  2020-07-13       Impact factor: 4.379

6.  A novel PAX5 rearrangement in TCF3-PBX1 acute lymphoblastic leukemia: a case report.

Authors:  Thayana Conceição Barbosa; Bruno Almeida Lopes; Caroline Barbieri Blunck; Marcela Braga Mansur; Adriana Vanessa Santini Deyl; Mariana Emerenciano; Maria S Pombo-de-Oliveira
Journal:  BMC Med Genomics       Date:  2018-12-18       Impact factor: 3.063

7.  Advances in B-cell Precursor Acute Lymphoblastic Leukemia Genomics.

Authors:  Claire Schwab; Christine J Harrison
Journal:  Hemasphere       Date:  2018-06-20

8.  Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.

Authors:  Marketa Zaliova; Jan Stuchly; Lucie Winkowska; Alena Musilova; Karel Fiser; Martina Slamova; Julia Starkova; Martina Vaskova; Ondrej Hrusak; Lucie Sramkova; Jan Stary; Jan Zuna; Jan Trka
Journal:  Haematologica       Date:  2019-01-10       Impact factor: 9.941

Review 9.  The Biology of B-Progenitor Acute Lymphoblastic Leukemia.

Authors:  Kathryn G Roberts; Charles G Mullighan
Journal:  Cold Spring Harb Perspect Med       Date:  2020-07-01       Impact factor: 5.159

Review 10.  New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia.

Authors:  Jan Starý; Jan Zuna; Marketa Zaliova
Journal:  F1000Res       Date:  2018-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.